Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Diabetologia|November 24, 2007
Diabetic polyneuropathy is associated with respiratory muscle impairment in type 2 diabetesH-J Kabitz, F Sonntag, D Walker, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 14, 2016
Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertensionS A Potthoff, S Stamer, K Grave, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 3, 2009
Evaluation of a standardized protocol for processing adrenal tumor samples: preparation for a European adrenal tumor bankI K Johnsen, S Hahner, J-J Brière, et al.
Endocrinology|February 11, 2014
Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomasP Tauber, D Penton, J Stindl, et al.
Journal of Molecular Endocrinology|December 15, 2016
Genetic characterization of a mouse line with primary aldosteronismL G Perez-Rivas, Y Rhayem, S Sabrautzki, et al.
Human Pathology|March 4, 2003
High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patientsW Saeger, M Fassnacht, R Chita, et al.
Molecular Psychiatry|November 4, 2009
Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuitsA Neufeld-Cohen, A K Evans, D Getselter, et al.
The Journal of Endocrinology|February 7, 2008
A highly sensitive immunofluorometric assay for the measurement of aldosterone in small sample volumes: validation in mouse serumJ Manolopoulou, M Bielohuby, S J Caton, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2009
Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's RegistryE Born-Frontsberg, M Reincke, L C Rump, et al.
Oncogenesis|July 28, 2015
Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinomaL Lefèvre, H Omeiri, L Drougat, et al.
Pageof 9